No Data
No Data
MediPharm Labs "Materially" Debt-Free After $2.1 Million Debt Payment
MediPharm Labs Corp. (MEDIF) Q2 2024 Earnings Call Transcript Summary
Press Release: MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders
MediPharm Labs Corp. Brief: Anticipates Further Improvement on Profitability in 2024 With Plans Being Implemented to Improve Adjusted EBITDA by a Further $1-$2 Million
MediPharm Labs Corp. Brief: Revenue Increased 67% to $9.8 Million During the Three Months Ended March 31, 2024, Versus Revenue for the Same Quarter in 2023 of $5.8 Million
Earnings Call Summary | MEDIPHARM LABS CORP(MEDIF.US) Q4 2023 Earnings Conference
No Data